Arginine 383 is a crucial residue in ABCG2 biogenesis

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 7, 2009, Pages 1434-1443

  Polgar, Orsolya ^a   Ediriwickrema, Lilangi S ^a   Robey, Robert W ^a   Sharma, Ajay ^b   Hegde, Ramanujan S ^b   Li, Yongfu ^a   Xia, Di ^a   Ward, Yvona ^a   Dean, Michael ^c   Ozvegy Laczka, Csilla ^d   Sarkadi, Balazs ^d   Bates, Susan E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL MEDICAL CENTER   (Hungary)

Author keywords

ABC transporter; ABCG2; Biogenesis; Membrane protein; Mutagenesis

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; ALANINE; ARGININE; BREAST CANCER RESISTANCE PROTEIN; GLYCINE; KIFUNENSINE; LYSINE; MITOXANTRONE; PHEOPHORBIDE; PROTEASOME; ABCG2 PROTEIN, HUMAN; TUMOR PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BIOGENESIS; CANCER CELL CULTURE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INSECT CELL; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION;

HEXAPODA;

AMINO ACID SEQUENCE; ANIMALS; ARGININE; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS;

EID: 68149114480     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.04.016     Document Type: Article

References (66)

1. Dean M., Hamon Y., and Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res. 42 (2001) 1007-1017
2. Allikmets R., Schriml L.M., Hutchinson A., Romano-Spica V., and Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58 (1998) 5337-5339
3. Miyake K., Mickley L., Litman T., Zhan Z., Robey R., Cristensen B., Brangi M., Greenberger L., Dean M., Fojo T., and Bates S.E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 59 (1999) 8-13
4. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., and Ross D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15665-15670
5. Robey R.W., Medina-Perez W.Y., Nishiyama K., Lahusen T., Miyake K., Litman T., Senderowicz A.M., Ross D.D., and Bates S.E. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (MXR/BCRP/ABCP1), in flavopiridol-resistant human breast cancer cells. Clin. Cancer Res. 7 (2001) 145-152
6. Chen Z.S., Robey R.W., Belinsky M.G., Shchaveleva I., Ren X.Q., Sugimoto Y., Ross D.D., Bates S.E., and Kruh G.D. Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-d-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res. 63 (2003) 4048-4054
7. Kawabata S., Oka M., Shiozawa K., Tsukamoto K., Nakatomi K., Soda H., Fukuda M., Ikegami Y., Sugahara K., Yamada Y., Kamihira S., Doyle L.A., Ross D.D., and Kohno S. Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem. Biophys. Res. Commun. 280 (2001) 1216-1223
8. Maliepaard M., van Gastelen M.A., de Jong L.A., Pluim D., van Waardenburg R.C., Ruevekamp-Helmers M.C., Floot B.G., and Schellens J.H. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res. 59 (1999) 4559-4563
9. Ozvegy-Laczka C., Hegedus T., Varady G., Ujhelly O., Schuetz J.D., Varadi A., Keri G., Orfi L., Nemet K., and Sarkadi B. High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter. Mol. Pharmacol. 65 (2004) 1485-1495
10. Elkind N.B., Szentpetery Z., Apati A., Ozvegy-Laczka C., Varady G., Ujhelly O., Szabo K., Homolya L., Varadi A., Buday L., Keri G., Nemet K., and Sarkadi B. Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib). Cancer Res. 65 (2005) 1770-1777
11. Burger H., van Tol H., Boersma A.W., Brok M., Wiemer E.A., Stoter G., and Nooter K. Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump. Blood 104 (2004) 2940-2942
12. Krishnamurthy P., and Schuetz J.D. Role of ABCG2/BCRP in biology and medicine. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 381-410
13. Rabindran S.K., He H., Singh M., Brown E., Collins K.I., Annable T., and Greenberger L.M. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res. 58 (1998) 5850-5858
14. Allen J.D., van Loevezijn A., Lakhai J.M., van der Valk M., van Tellingen O., Reid G., Schellens J.H.M., Koomen G.-J., and Schinkel A.H. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 1 (2002) 417-425
15. Zhou S., Morris J.J., Barnes Y., Lan L., Schuetz J.D., and Sorrentino B.P. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12339-12344
16. Ozvegy C., Litman T., Szakacs G., Nagy Z., Bates S., Varadi A., and Sarkadi B. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem. Biophys. Res. Commun. 285 (2001) 111-117
17. Henriksen U., Gether U., and Litman T. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2. J. Cell. Sci. 118 (2005) 1417-1426
18. Bhatia A., Schafer H.J., and Hrycyna C.A. Oligomerization of the human ABC transporter ABCG2: evaluation of the native protein and chimeric dimers. Biochemistry 44 (2005) 10893-10904
19. Xu J., Liu Y., Yang Y., Bates S., and Zhang J.T. Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J. Biol. Chem. 279 (2004) 19781-19789
20. McDevitt C.A., Collins R.F., Conway M., Modok S., Storm J., Kerr I.D., Ford R.C., and Callaghan R. Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2. Structure 14 (2006) 1623-1632
21. Diop N.K., and Hrycyna C.A. N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane. Biochemistry 44 (2005) 5420-5429
22. Xie Y., Xu K., Linn D.E., Yang X., Guo Z., Shimelis H., Nakanishi T., Ross D.D., Chen H., Fazli L., Gleave M.E., and Qiu Y. The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells. J. Biol. Chem. 283 (2008) 3349-3356
23. Henriksen U., Fog J.U., Litman T., and Gether U. Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2. J. Biol. Chem. 280 (2005) 36926-36934
24. Li Y.F., Polgar O., Okada M., Esser L., Bates S.E., and Xia D. Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: a molecular modeling study. J. Mol. Graph. Model. 25 (2007) 837-851
25. Chang G. Retraction of "Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation" [J. Mol. Biol. (2003) 330 419-430]. J. Mol. Biol. 369 (2007) 596
26. Polgar O., Robey R.W., Morisaki K., Dean M., Michejda C., Sauna Z.E., Ambudkar S.V., Tarasova N., and Bates S.E. Mutational analysis of ABCG2: role of the GXXXG motif. Biochemistry 43 (2004) 9448-9456
27. Robey R.W., Honjo Y., Morisaki K., Nadjem T.A., Runge S., Risbood M., Poruchynsky M.S., and Bates S.E. Mutations at amino acid 482 in the ABCG2 gene affect substrate and antagonist specificity. Br. J. Cancer 89 (2003) 1971-1978
28. Hegde R.S., Voigt S., and Lingappa V.R. Regulation of protein topology by trans-acting factors at the endoplasmic reticulum. Mol. Cell 2 (1998) 85-91
29. Polgar O., Ozvegy-Laczka C., Robey R.W., Morisaki K., Okada M., Tamaki A., Koblos G., Elkind N.B., Ward Y., Dean M., Sarkadi B., and Bates S.E. Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization. Bichemistry (2006)
30. Ozvegy C., Varadi A., and Sarkadi B. Characterization of drug transport, ATP hydrolysis and nucleotide trapping by the human ABCG2 multidrug transporter: modulation of substrate specificity by a point mutation. J. Biol. Chem. 277 (2002) 47980-47990
31. Ozvegy-Laczka C., Varady G., Koblos G., Ujhelly O., Cervenak J., Schuetz J.D., Sorrentino B.P., Koomen G.J., Varadi A., Nemet K., and Sarkadi B. Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface. J. Biol. Chem. 280 (2005) 4219-4227
32. Muller M., Bakos E., Welker E., Varadi A., Germann U.A., Gottesman M.M., Morse B.S., Roninson I.B., and Sarkadi B. Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein. J. Biol. Chem. 271 (1996) 1877-1883
33. Sarkadi B., Price E., Boucher R., Germann U., and Scarborough G. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated ATPase. J. Biol. Chem. 267 (1992) 4854-4858
34. Honjo Y., Hrycyna C.A., Yan Q.W., Medina-Perez W.Y., Robey R.W., van de Laar A., Litman T., Dean M., and Bates S.E. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res. 61 (2001) 6635-6639
35. Robey R.W., Steadman K., Polgar O., Morisaki K., Blayney M., Mistry P., and Bates S.E. Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res. 64 (2004) 1242-1246
36. Litman T., Jensen U., Hansen A., Covitz K., Zhan Z., Fetsch P., Abati A., Hansen P., Horn T., Skovsgaard T., and Bates S. Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2. Biochim. Biophys. Acta 1565 (2002) 6-16
37. Spiro R.G. Role of N-linked polymannose oligosaccharides in targeting glycoproteins for endoplasmic reticulum-associated degradation. Cell. Mol. Life Sci. 61 (2004) 1025-1041
38. Loo T.W., and Clarke D.M. Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators. J. Biol. Chem. 272 (1997) 709-712
39. Denning G.M., Anderson M.P., Amara J.F., Marshall J., Smith A.E., and Welsh M.J. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358 (1992) 761-764
40. Altmann F., Staudacher E., Wilson I.B., and Marz L. Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj. J. 16 (1999) 109-123
41. Lu K., Lee M.H., Hazard S., Brooks-Wilson A., Hidaka H., Kojima H., Ose L., Stalenhoef A.F., Mietinnen T., Bjorkhem I., Bruckert E., Pandya A., Brewer Jr. H.B., Salen G., Dean M., Srivastava A., and Patel S.B. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am. J. Hum. Genet. 69 (2001) 278-290
42. Wallin E., and von Heijne G. Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci. 7 (1998) 1029-1038
43. Pinkett H.W., Lee A.T., Lum P., Locher K.P., and Rees D.C. An inward-facing conformation of a putative metal-chelate-type ABC transporter. Science 315 (2007) 373-377
44. Locher K.P., Lee A.T., and Rees D.C. The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism. Science 296 (2002) 1091-1098
45. Dawson R.J., and Locher K.P. Structure of a bacterial multidrug ABC transporter. Nature 443 (2006) 180-185
46. Hollenstein K., Frei D.C., and Locher K.P. Structure of an ABC transporter in complex with its binding protein. Nature 446 (2007) 213-216
47. Ward A., Reyes C.L., Yu J., Roth C.B., and Chang G. Flexibility in the ABC transporter MsbA: alternating access with a twist. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 19005-19010
48. Oldham M.L., Khare D., Quiocho F.A., Davidson A.L., and Chen J. Crystal structure of a catalytic intermediate of the maltose transporter. Nature 450 (2007) 515-521
49. Zolnerciks J.K., Wooding C., and Linton K.J. Evidence for a Sav1866-like architecture for the human multidrug transporter P-glycoprotein. FASEB J. 21 (2007) 3937-3948
50. Miwa M., Tsukahara S., Ishikawa E., Asada S., Imai Y., and Sugimoto Y. Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants. Int. J. Cancer 107 (2003) 757-763
51. Ozvegy-Laczka C., Koblos G., Sarkadi B., and Varadi A. Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition. Biochim. Biophys. Acta 1668 (2005) 53-63
52. Pozza A., Perez-Victoria J.M., Sardo A., Ahmed-Belkacem A., and Di Pietro A. Purification of breast cancer resistance protein ABCG2 and role of arginine-482. Cell. Mol. Life Sci. 63 (2006) 1912-1922
53. Ejendal K.F., Diop N.K., Schweiger L.C., and Hrycyna C.A. The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding. Protein Sci. 15 (2006) 1597-1607
54. Conrad S., Kauffmann H.M., Ito K., Leslie E.M., Deeley R.G., Schrenk D., and Cole S.P. A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance. Pharmacogenetics 12 (2002) 321-330
55. Conseil G., Deeley R.G., and Cole S.P. Functional importance of three basic residues clustered at the cytosolic interface of transmembrane helix 15 in the multidrug and organic anion transporter MRP1 (ABCC1). J. Biol. Chem. 281 (2006) 43-50
56. Ren X.Q., Furukawa T., Aoki S., Sumizawa T., Haraguchi M., Nakajima Y., Ikeda R., Kobayashi M., and Akiyama S. A positively charged amino acid proximal to the C-terminus of TM17 of MRP1 is indispensable for GSH-dependent binding of substrates and for transport of LTC4. Biochemistry 41 (2002) 14132-14140
57. Haimeur A., Conseil G., Deeley R.G., and Cole S.P. Mutations of charged amino acids in or near the transmembrane helices of the second membrane spanning domain differentially affect the substrate specificity and transport activity of the multidrug resistance protein MRP1 (ABCC1). Mol. Pharmacol. 65 (2004) 1375-1385
58. Sitia R., and Braakman I. Quality control in the endoplasmic reticulum protein factory. Nature 426 (2003) 891-894
59. Wakabayashi K., Nakagawa H., Tamura A., Koshiba S., Hoshijima K., Komada M., and Ishikawa T. Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein. J. Biol. Chem. 282 (2007) 27841-27846
60. Nakagawa H., Tamura A., Wakabayashi K., Hoshijima K., Komada M., Yoshida T., Kometani S., Matsubara T., Mikuriya K., and Ishikawa T. Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2. Biochem. J. 411 (2008) 623-631
61. Jensen T.J., Loo M.A., Pind S., Williams D.B., Goldberg A.L., and Riordan J.R. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83 (1995) 129-135
62. Ward C.L., Omura S., and Kopito R.R. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83 (1995) 121-127
63. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.L., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989) 1066-1073
64. Loo T.W., Bartlett M.C., and Clarke D.M. Rescue of folding defects in ABC transporters using pharmacological chaperones. J. Bioenerg. Biomembr. 37 (2005) 501-507
65. Engelman J.A., Janne P.A., Mermel C., Pearlberg J., Mukohara T., Fleet C., Cichowski K., Johnson B.E., and Cantley L.C. ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3788-3793
66. von Heijne G. Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J. Mol. Biol. 225 (1992) 487-494